Browsing by Author "Paz-Ares, Luis"
Now showing items 1-5 of 5
-
First-Line Nivolumab Plus Ipilimumab With Chemotherapy Versus Chemotherapy Alone for Metastatic NSCLC in CheckMate 9LA: 3-Year Clinical Update and Outcomes in Patients With Brain Metastases or Select Somatic Mutations
Paz-Ares, Luis; Ciuleanu, Tudor Eliade; Bennouna, Jaafar; Schenker, Michael; Cheng, Ying; FELIP, ENRIQUETA; Cobo, Manuel (Elsevier, 2023-02) -
LungBEAM: A prospective multicenter study to monitor stage IV NSCLC patients with EGFR mutations using BEAMing technology
Garrido, Pilar; Paz-Ares, Luis; Majem Tarruella, Margarita; Morán, Teresa; Trigo, José Manuel; Bosch-Barrera, J; Felip Font, Enriqueta (Wiley, 2021-09) -
Nueva actualización de las recomendaciones para la determinación de biomarcadores predictivos en el carcinoma de pulmón no célula pequeña: Consenso Nacional de la Sociedad Española de Anatomía Patológica y de la Sociedad Española de Oncología Médica
Isla, Dolores; Lozano, Maria D.; Paz-Ares, Luis; Salas Antón, Clara; Conde, Esther; De Castro, Javier; FELIP, ENRIQUETA (Elsevier, 2023-04) -
Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial
Cassier, Phillippe A.; Siena , Salvatore; Garralda Cabanas, Elena; Paz-Ares, Luis; Garrido, Pilar; Subbiah, Vivek (Nature Research, 2022-08) -
Phase II study of afatinib plus pembrolizumab in patients with squamous cell carcinoma of the lung following progression during or after first-line chemotherapy (LUX-Lung-IO)
Levy, Benjamin; Barlesi, Fabrice; Paz-Ares, Luis; Bennouna, Jaafar; Erman, Mustafa; Felip Font, Enriqueta; Isla, Dolores (Elsevier, 2022-04)